AR115942A2 - STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A AND CONTAINING CONTAINERS - Google Patents

STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A AND CONTAINING CONTAINERS

Info

Publication number
AR115942A2
AR115942A2 ARP190102272A ARP190102272A AR115942A2 AR 115942 A2 AR115942 A2 AR 115942A2 AR P190102272 A ARP190102272 A AR P190102272A AR P190102272 A ARP190102272 A AR P190102272A AR 115942 A2 AR115942 A2 AR 115942A2
Authority
AR
Argentina
Prior art keywords
arisulfatase
pharmaceutical compositions
stable pharmaceutical
administration
containing containers
Prior art date
Application number
ARP190102272A
Other languages
Spanish (es)
Original Assignee
Shire Human Genetic Therapies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Human Genetic Therapies filed Critical Shire Human Genetic Therapies
Publication of AR115942A2 publication Critical patent/AR115942A2/en

Links

Abstract

La presente se refiere a la administración intratecal de enzimas lisosomales para el tratamiento eficaz de enfermedades de almacenamiento lisosomal En algunas formas de realización, la presente proporciona formulaciones estables para la administración IT de Arilsulfatasa A.The present relates to the intrathecal administration of lysosomal enzymes for the effective treatment of lysosomal storage diseases. In some embodiments, the present provides stable formulations for IT administration of Arylsulfatase A.

ARP190102272A 2010-06-25 2019-08-09 STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A AND CONTAINING CONTAINERS AR115942A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35885710P 2010-06-25 2010-06-25

Publications (1)

Publication Number Publication Date
AR115942A2 true AR115942A2 (en) 2021-03-17

Family

ID=75905105

Family Applications (4)

Application Number Title Priority Date Filing Date
ARP190102272A AR115942A2 (en) 2010-06-25 2019-08-09 STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A AND CONTAINING CONTAINERS
ARP210101255A AR122036A2 (en) 2010-06-25 2021-05-07 STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A
ARP210103195A AR124100A2 (en) 2010-06-25 2021-11-18 PHARMACEUTICAL COMPOSITIONS FOR THE INTRATHECAL ADMINISTRATION OF LYSOSOMIC ENZYMES
ARP210103544A AR124399A2 (en) 2010-06-25 2021-12-16 STABLE FORMULATIONS FOR THE INTRATHECAL ADMINISTRATION OF IDURANATE-2-SULFATASE

Family Applications After (3)

Application Number Title Priority Date Filing Date
ARP210101255A AR122036A2 (en) 2010-06-25 2021-05-07 STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A
ARP210103195A AR124100A2 (en) 2010-06-25 2021-11-18 PHARMACEUTICAL COMPOSITIONS FOR THE INTRATHECAL ADMINISTRATION OF LYSOSOMIC ENZYMES
ARP210103544A AR124399A2 (en) 2010-06-25 2021-12-16 STABLE FORMULATIONS FOR THE INTRATHECAL ADMINISTRATION OF IDURANATE-2-SULFATASE

Country Status (1)

Country Link
AR (4) AR115942A2 (en)

Also Published As

Publication number Publication date
AR124399A2 (en) 2023-03-22
AR122036A2 (en) 2022-08-03
AR124100A2 (en) 2023-02-15

Similar Documents

Publication Publication Date Title
AR081678A1 (en) METHODS AND COMPOSITIONS FOR INTRATECAL ADMINISTRATION OF ARISULFATASE A
CY1124910T1 (en) METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLOSULFATASE A
NZ717728A (en) Stable formulations of a hyaluronan-degrading enzyme
MX352823B (en) Protein formulations containing amino acids.
IN2012DN06720A (en)
BR112014004460A2 (en) polymeric material for an insulated container
MA38096A1 (en) Stable mydriatic and anti-inflammatory solutions without preservatives to be injected
PE20150762A1 (en) ETANERCEPT FORMULATIONS SHOWING A MARKED REDUCTION IN THE AMOUNT OF SUBVISIBLE PARTICLES
BR112012032008A2 (en) s100a4 antibodies and therapeutic uses thereof
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
TN2013000386A1 (en) Suspension type topical formulations comprising cyclic depsipeptide
AR082215A1 (en) PHARMACEUTICAL COMPOSITION NICE TO THE PALATE
TR201009167A2 (en) Pharmaceutical granules containing cephalosporin.
MX2014006574A (en) Acamprosate formulations, methods of using the same, and combinations comprising the same.
AR115942A2 (en) STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A AND CONTAINING CONTAINERS
IN2014CN04119A (en)
ECSP13012765A (en) COMBINATION AND COMPOSITION FOR OBESITY TREATMENT
CO6751242A2 (en) Combination and composition for the treatment of obesity
MA33055B1 (en) NOVEL COMBINATION OF ACTIVE INGREDIENTS CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY AND COLCHICOSIDE DERIVATIVE
UY30368A1 (en) 2-ALCOXI-3,4,5-TRIHIDROXI-ALQUILAMIDA-BENZAZEPINAS, ITS PREPARATION, COMPOSITIONS THAT CONTAIN AND USE
CO7240380A2 (en) Pediatric oral liquid compositions containing nepadutant
EA201190243A1 (en) STABLE PHARMACEUTICAL COMPOSITION OF FLUDARABIN PHOSPHATE
UA97076C2 (en) Anti-inflammatory ointment based on sulfanilamide
MY184940A (en) Lignosus rhinocerus (tiger-milk mushroom) as anti-inflammatory agent
CL2015002906A1 (en) Supply to the central nervous system of therapeutic agents (divisional application 3656-2012)